48,830
edits
(→Anti-MPO antibodies: rework) |
|||
Line 40: | Line 40: | ||
**[[Amyloidosis]]. | **[[Amyloidosis]]. | ||
=== | ===ANCA antibodies=== | ||
Types:<ref>{{Cite journal | last1 = Kallenberg | first1 = CG. | title = Pathogenesis of ANCA-associated vasculitides. | journal = Ann Rheum Dis | volume = 70 Suppl 1 | issue = | pages = i59-63 | month = Mar | year = 2011 | doi = 10.1136/ard.2010.138024 | PMID = 21339221 }}</ref> | |||
</ref> | *MPO-ANCA (myeloperoxidase antineutrophil cytoplasmic autoantibody). | ||
**Previously p-ANCA. | |||
**Seen in ANCA-[[vasculitides]], esp. [[microscopic polyangiitis]]. | |||
*PR3-ANPA (proteinase 3 antineutrophil cytoplasmic autoantibody). | |||
**Previously c-ANCA. | |||
****Seen in ANCA-[[vasculitides]], esp. [[Wegener granulomatosis]]. | |||
===C4d=== | ===C4d=== |
edits